Oncogenic lncRNA ZNFX1 antisense RNA 1 promotes osteosarcoma cells proliferation and metastasis by stabilizing serine and arginine‑rich splicing factor 3

References

• Kansara M, Teng MW, Smyth MJ, et al. Translational biology of osteosarcoma. Nat Rev Cancer. 2014;14:722–735.
   PubMed Web of Science ®Google Scholar
• Whelan JS, Davis LE. Osteosarcoma, chondrosarcoma, and chordoma. J Clin Oncol. 2018;36:188–193.
   PubMed Web of Science ®Google Scholar
• Gill J, Gorlick R. Advancing therapy for osteosarcoma. Nat Rev Clin Oncol. 2021;18(10):609–624.
   PubMed Web of Science ®Google Scholar
• Demetri GD, Luke JJ, Hollebecque A, et al. First-in-human phase i study of ABBV-085, an Antibody–drug conjugate targeting LRRC15, in sarcomas and other advanced solid tumors. Clin Cancer Res. 2021;27(13):3556–3566.
   PubMed Web of Science ®Google Scholar
• Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47–62.
   PubMed Web of Science ®Google Scholar
• Yang Z, Jiang S, Shang J, et al. LncRNA: shedding light on mechanisms and opportunities in fibrosis and aging. Ageing Res Rev. 2019;52:17–31.
   PubMed Web of Science ®Google Scholar
• Bao M-H, Szeto V, Yang BB, et al. Long non-coding RNAs in ischemic stroke. Cell Death Dis. 2018;9(3):281.
   PubMed Web of Science ®Google Scholar
• Beermann J, Piccoli M-T, Viereck J, et al. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016;96(4):1297–1325.
   PubMed Web of Science ®Google Scholar
• Klingenberg M, Matsuda A, Diederichs S, et al. Non-coding RNA in hepatocellular carcinoma: mechanisms, biomarkers and therapeutic targets. J Hepatol. 2017;67(3):603–618.
   PubMed Web of Science ®Google Scholar
• Crudele F, Bianchi N, Reali E, et al. The network of non-coding RNAs and their molecular targets in breast cancer. Mol Cancer. 2020;19:61.
   PubMed Web of Science ®Google Scholar
• Dykes IM, Emanueli C. Transcriptional and post-transcriptional gene regulation by long non-coding RNA. Genomics Proteomics Bioinformatics. 2017;15:177–186.
   PubMed Web of Science ®Google Scholar
• Zhu KP, Zhang CL, Ma XL, et al. Analyzing the interactions of mRNAs and ncRNAs to predict competing endogenous RNA networks in osteosarcoma chemo-resistance. Mol Ther. 2019;27:518–530.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zeng X, Wang N, et al. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma. Mol Cancer. 2018;17:89.
   PubMed Web of Science ®Google Scholar
• Zhao W, Zhang D, Qin P, et al. Long non-coding RNA EPIC1 inhibits viability and invasion of osteosarcoma cells by promoting MEF2D ubiquitylation. Int J Biol Macromol. 2019;128:566–573.
   PubMed Web of Science ®Google Scholar
• Dai J, Xu LJ, Han GD, et al. Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/beta-catenin signalling and predicts favourable prognosis. Artif Cells Nanomed Biotechnol. 2018;46:S783–S90.
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Shirvani-Farsani Z, Hussen BM, et al. The critical roles of lncRNAs in the development of osteosarcoma. Biomed Pharmacother. 2021;135:111217.
   PubMed Web of Science ®Google Scholar
• Yang Z, Li X, Yang Y, et al. Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma. Cell Death Dis. 2016;7:e2389.
   PubMed Web of Science ®Google Scholar
• Wu H, Qin W, Lu S, et al. Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2’-O-methylation via NOP58 recruitment in colorectal cancer. Mol Cancer. 2020;19:95.
   PubMed Web of Science ®Google Scholar
• Li Z, Qin X, Bian W, et al. Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis. J Exp Clin Cancer Res. 2019;38:477.
   PubMed Web of Science ®Google Scholar
• Han J, Shen X. Long noncoding RNAs in osteosarcoma via various signaling pathways. J Clin Lab Anal. 2020;34:e23317.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Lin X, Tong Y, et al. Silencing lncRNA ZFAS1 or elevated microRNA-135a represses proliferation, migration, invasion and resistance to apoptosis of osteosarcoma cells. Cancer Cell Int. 2019;19:326.
   PubMed Web of Science ®Google Scholar
• Zhu C, Zhang C, Cui X, et al. Trichosanthin inhibits cervical cancer by regulating oxidative stress-induced apoptosis. Bioengineered. 2021;12:2779–2790.
   PubMed Web of Science ®Google Scholar
• Pan G, Zhang J, You F, et al. ETS proto-oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1. Bioengineered. 2022;13:1346–1358.
   PubMed Web of Science ®Google Scholar
• Soliman H, Ferrari A, Thomas D. Sarcoma in the young adult population: an international view. Semin Oncol. 2009;36:227–236.
   PubMed Web of Science ®Google Scholar
• Li Z, Shen J, Chan MTV, et al. The long non-coding RNA SPRY4-IT1: an emerging player in tumorigenesis and osteosarcoma. Cell Prolif. 2018;51:e12446.
   PubMed Web of Science ®Google Scholar
• Zhou FC, Zhang YH, Liu HT, et al. LncRNA LINC00588 suppresses the progression of osteosarcoma by acting as a ceRNA for miRNA-1972. Front Pharmacol. 2020;11:255.
   PubMed Web of Science ®Google Scholar
• Zhang CL, Zhu KP, Ma XL. Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2. Cancer Lett. 2017;396:66–75.
   PubMed Web of Science ®Google Scholar
• Liu G, Wang L, Han H, et al. LncRNA ZFAS1 promotes growth and metastasis by regulating BMI1 and ZEB2 in osteosarcoma. Am J Cancer Res. 2017;7:1450–1462.
   PubMed Web of Science ®Google Scholar
• Liu CW, Liu D, Peng D. Long non-coding RNA ZFAS1 regulates NOB1 expression through interacting with miR-646 and promotes tumorigenesis in osteosarcoma. Eur Rev Med Pharmacol Sci. 2019;23:3206–3216.
   PubMed Web of Science ®Google Scholar
• Ajiro M, Jia R, Yang Y, et al. A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells. Nucleic Acids Res. 2016;44:1854–1870.
   PubMed Web of Science ®Google Scholar
• Zhou J, Wu G, Tong Z, et al. Prognostic relevance of SMC family gene expression in human sarcoma. Aging (Albany NY). 2020;13:1473–1487.
   PubMedGoogle Scholar
• Kato T, Wada H, Patel P, et al. Overexpression of KIF23 predicts clinical outcome in primary lung cancer patients. Lung Cancer. 2016;92:53–61.
   PubMed Web of Science ®Google Scholar
• Feng J, Lu -S-S, Xiao T, et al. ANXA1 binds and stabilizes EphA2 to promote nasopharyngeal carcinoma growth and metastasis. Cancer Res. 2020;80(20):4386–4398.
   PubMed Web of Science ®Google Scholar
• Zhang M, Weng W, Zhang Q, et al. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5. J Hematol Oncol. 2018;11(1):113.
   PubMedGoogle Scholar